Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus

Documents similaires

• Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
  par: Lijun Zhao, et autres
  Publié: (2024)
• The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021
  par: Omar Al Ta'ani, et autres
  Publié: (2024)
• Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER )
  par: Lauren Wilson, et autres
  Publié: (2026)
• Glucagon‐like peptide‐1 receptor agonist treatment reduces body weight and improves glycaemic outcomes in patients with concurrent overweight/obesity and type 1 diabetes: A systematic review and meta‐analysis
  par: Amanda R. Purcell, et autres
  Publié: (2025)
• Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
  par: Testimony Ipaye, et autres
  Publié: (2025)